114 related articles for article (PubMed ID: 2790969)
1. The "public" determinants HLA-Bw4/Bw6 do not generate cytotoxic T lymphocytes (CTLs).
López-Larrea C; Arnaiz-Villena A
Cell Immunol; 1989 Oct; 123(2):441-4. PubMed ID: 2790969
[TBL] [Abstract][Full Text] [Related]
2. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
[TBL] [Abstract][Full Text] [Related]
3. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes.
Clayberger C; Rosen M; Parham P; Krensky AM
J Immunol; 1990 Jun; 144(11):4172-6. PubMed ID: 2341716
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
[TBL] [Abstract][Full Text] [Related]
5. Cell mediated PPD specific cytotoxicity against human monocyte targets: III. Cellular typing with CTLs restricted by class II HLA antigens.
Hansen PW; Kristensen T
Tissue Antigens; 1986 Apr; 27(4):227-38. PubMed ID: 2425454
[TBL] [Abstract][Full Text] [Related]
6. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
7. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
8. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
Yamamoto J; Kariyone A; Akiyama N; Kano K; Takiguchi M
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2583-7. PubMed ID: 2157206
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?
Demanet C; Mulder A; Deneys V; Worsham MJ; Maes P; Claas FH; Ferrone S
Blood; 2004 Apr; 103(8):3122-30. PubMed ID: 15070694
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
Lutz CT
Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
[TBL] [Abstract][Full Text] [Related]
12. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
[TBL] [Abstract][Full Text] [Related]
13. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
[TBL] [Abstract][Full Text] [Related]
14. Effect of Bw4 and Bw6 epitope mismatches on antibody production, acute and chronic rejection, and graft survival in renal allografts.
Leffell MS; Kraus E; Racusen LC; Ratner LE; Charney D; Zachary AA
Transplantation; 2001 Aug; 72(3):433-7. PubMed ID: 11502972
[TBL] [Abstract][Full Text] [Related]
15. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
[TBL] [Abstract][Full Text] [Related]
16. A public HLA antigen associated with HLA-A9, Aw32, and Bw4.
Kostyu DD; Cresswell P; Amos DB
Immunogenetics; 1980; 10(5):433-42. PubMed ID: 22457917
[TBL] [Abstract][Full Text] [Related]
17. Genetics of cell-mediated lympholysis (CML) in man.
Singal DP; Wadia YJ
Tissue Antigens; 1980 Feb; 15(2):177-88. PubMed ID: 12735318
[TBL] [Abstract][Full Text] [Related]
18. Functional cell mediated lympholysis: II. Genetics.
Goeken NE; Thompson JS
Tissue Antigens; 1981; 17(4):411-20. PubMed ID: 6949337
[TBL] [Abstract][Full Text] [Related]
19. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
[TBL] [Abstract][Full Text] [Related]
20. Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.
Kolstad A; Toubert A; Weyl D; Jun G; Hannestad K
Hum Immunol; 1992 Jun; 34(2):77-84. PubMed ID: 1385373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]